Hermann Brenner1, Nadine Zwink, Leopold Ludwig, Michael Hoffmeister. 1. Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ, Deutsches Krebsforschungszentrum), Heidelberg, Germany; Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany; German Consortium for Translational Cancer Research (DKTK, Deutsches Konsortium für Translationale Krebsforschung), German Cancer Research Center (DKFZ), Heidelberg, Germany; Gastroenterology and Internal Medicine Practice, Dornstadt, Germany.
Abstract
BACKGROUND: The introduction of colonoscopic screening in 2002 for persons aged 55 and older was followed by a marked decline in the incidence of colon cancer in the corresponding age groups in Germany. The prevalence of colorectal neoplasia among persons aged 50 to 54 has remained unknown until now. Expert committees currently recommend colonoscopic screening for persons aged 50 and older. This option has been offered since 2014 by the AOK Baden-Württemberg and by Bosch BKK in the framework of their specialized medical care program. METHODS:In April 2014 and 2015, 84 726 insurees aged 50-54 were invited by mail to participate in colonoscopic screening. The utilization and results of colonoscopic screening were studied. A questionnaire about risks was additionally sent to half of the participants, who were selected at random (study registration: DRKS00006268). RESULTS: Within one year, 1.9% of persons to whom invitations had been sent took up the offer of colonoscopic screening; these persons included 3.3% of those already enrolled in the specialized medical care program. The 1396 colonoscopies that were performed revealed advanced neoplasia (colon cancer or advanced adenoma) in 6.8% of cases. The prevalence of advanced neoplasia among men aged 50 to 54 was nearly twice as high as that among women in the same age group (8.6% vs. 4.5%, p = 0.0027). It was also higher than the prevalences documented in the German nationwide cancer registry for women aged 55 to 79. The additional sending of a risk questionnaire along with the invitation had no effect on the rate of detection of relevant findings or on the rate of participation in colonoscopic screening. CONCLUSION: These findings lend support to the demand that the offer of colonoscopic screening should be extended at least to men aged 50 and above.
RCT Entities:
BACKGROUND: The introduction of colonoscopic screening in 2002 for persons aged 55 and older was followed by a marked decline in the incidence of colon cancer in the corresponding age groups in Germany. The prevalence of colorectal neoplasia among persons aged 50 to 54 has remained unknown until now. Expert committees currently recommend colonoscopic screening for persons aged 50 and older. This option has been offered since 2014 by the AOK Baden-Württemberg and by Bosch BKK in the framework of their specialized medical care program. METHODS: In April 2014 and 2015, 84 726 insurees aged 50-54 were invited by mail to participate in colonoscopic screening. The utilization and results of colonoscopic screening were studied. A questionnaire about risks was additionally sent to half of the participants, who were selected at random (study registration: DRKS00006268). RESULTS: Within one year, 1.9% of persons to whom invitations had been sent took up the offer of colonoscopic screening; these persons included 3.3% of those already enrolled in the specialized medical care program. The 1396 colonoscopies that were performed revealed advanced neoplasia (colon cancer or advanced adenoma) in 6.8% of cases. The prevalence of advanced neoplasia among men aged 50 to 54 was nearly twice as high as that among women in the same age group (8.6% vs. 4.5%, p = 0.0027). It was also higher than the prevalences documented in the German nationwide cancer registry for women aged 55 to 79. The additional sending of a risk questionnaire along with the invitation had no effect on the rate of detection of relevant findings or on the rate of participation in colonoscopic screening. CONCLUSION: These findings lend support to the demand that the offer of colonoscopic screening should be extended at least to men aged 50 and above.
Authors: C Pox; S Aretz; S C Bischoff; U Graeven; M Hass; P Heußner; W Hohenberger; A Holstege; J Hübner; F Kolligs; M Kreis; P Lux; J Ockenga; R Porschen; S Post; N Rahner; A Reinacher-Schick; J F Riemann; R Sauer; A Sieg; W Scheppach; W Schmitt; H J Schmoll; K Schulmann; A Tannapfel; W Schmiegel Journal: Z Gastroenterol Date: 2013-08-16 Impact factor: 2.000
Authors: Amir Qaseem; Thomas D Denberg; Robert H Hopkins; Linda L Humphrey; Joel Levine; Donna E Sweet; Paul Shekelle Journal: Ann Intern Med Date: 2012-03-06 Impact factor: 25.391
Authors: Aasma Shaukat; Steven J Mongin; Mindy S Geisser; Frank A Lederle; John H Bond; Jack S Mandel; Timothy R Church Journal: N Engl J Med Date: 2013-09-19 Impact factor: 91.245
Authors: Hermann Brenner; Lutz Altenhofen; Jens Kretschmann; Thomas Rösch; Christian Pox; Christian Stock; Michael Hoffmeister Journal: Gastroenterology Date: 2015-04-22 Impact factor: 22.682
Authors: Hermann Brenner; Petra Schrotz-King; Bernd Holleczek; Alexander Katalinic; Michael Hoffmeister Journal: Dtsch Arztebl Int Date: 2016-02-19 Impact factor: 5.594
Authors: Frank T Kolligs; Alexander Crispin; Axel Munte; Andreas Wagner; Ulrich Mansmann; Burkhard Göke Journal: PLoS One Date: 2011-05-24 Impact factor: 3.240
Authors: Alexander Bauer; Jürgen F Riemann; Thomas Seufferlein; Max Reinshagen; Stephan Hollerbach; Ulrike Haug; Susanne Unverzagt; Stephanie Boese; Madeleine Ritter-Herschbach; Patrick Jahn; Thomas Frese; Michael Harris; Margarete Landenberger Journal: Dtsch Arztebl Int Date: 2018-10-26 Impact factor: 5.594
Authors: K Stratmann; H Bock; N Filmann; P Fister; C Weber; W Tacke; B Simonis; M Höftmann; O Schröder; J Hausmann; S Zeuzem; I Blumenstein Journal: United European Gastroenterol J Date: 2018-04-16 Impact factor: 4.623
Authors: Alan White; Lucy Ironmonger; Robert J C Steele; Nick Ormiston-Smith; Carina Crawford; Amanda Seims Journal: BMC Cancer Date: 2018-09-20 Impact factor: 4.430
Authors: Jennifer M Kolb; Junxiao Hu; Kristen DeSanto; Dexiang Gao; Siddharth Singh; Thomas Imperiale; David A Lieberman; C Richard Boland; Swati G Patel Journal: Gastroenterology Date: 2021-06-10 Impact factor: 33.883